Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Hindmarsh

Showing results (41-50 of 194) with videos related to

Pageof 20
Sort By:
Archives of Disease in Childhood|January 1, 1993
Compliance with growth hormone treatment--are they getting it?S L Smith, P C Hindmarsh, C G Brook
Clinical Endocrinology|November 1, 1995
Hexarelin induced growth hormone release is influenced by exogenous growth hormoneA F Massoud, P C Hindmarsh, C G Brook
Hormone Research|January 1, 1991
Growth of children with hypochondroplasia treated with growth hormone for up to three yearsN A Bridges, P C Hindmarsh, C G Brook
Acta Endocrinologica|March 1, 1988
The 24-hour growth hormone secretion in a boy with giantismP C Hindmarsh, P J Pringle, C G Brook
Clinical Endocrinology|September 1, 1988
Cholinergic muscarinic blockade produces short-term suppression of growth hormone secretion in children with tall statureP C Hindmarsh, P J Pringle, C G Brook
Archives of Disease in Childhood|October 23, 2004
Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiencyT J Cole, P C Hindmarsh, D B Dunger
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response studyA F Massoud, P C Hindmarsh, C G Brook
Archives of Disease in Childhood|June 5, 1998
Obesity in 21-hydroxylase deficient patientsR E Cornean, P C Hindmarsh, C G Brook
Archives of Disease in Childhood|January 1, 1993
Optimum method for growth hormone treatmentS L Smith, P C Hindmarsh, C G Brook
Clinical Endocrinology|April 10, 1999
The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumoursJ C Achermann, P C Hindmarsh, C G Brook
Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
Archives of Disease in Childhood|January 1, 1993
Compliance with growth hormone treatment--are they getting it?S L Smith, P C Hindmarsh, C G Brook
Clinical Endocrinology|November 1, 1995
Hexarelin induced growth hormone release is influenced by exogenous growth hormoneA F Massoud, P C Hindmarsh, C G Brook
Hormone Research|January 1, 1991
Growth of children with hypochondroplasia treated with growth hormone for up to three yearsN A Bridges, P C Hindmarsh, C G Brook
Acta Endocrinologica|March 1, 1988
The 24-hour growth hormone secretion in a boy with giantismP C Hindmarsh, P J Pringle, C G Brook
Clinical Endocrinology|September 1, 1988
Cholinergic muscarinic blockade produces short-term suppression of growth hormone secretion in children with tall statureP C Hindmarsh, P J Pringle, C G Brook
Archives of Disease in Childhood|October 23, 2004
Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiencyT J Cole, P C Hindmarsh, D B Dunger
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response studyA F Massoud, P C Hindmarsh, C G Brook
Archives of Disease in Childhood|June 5, 1998
Obesity in 21-hydroxylase deficient patientsR E Cornean, P C Hindmarsh, C G Brook
Archives of Disease in Childhood|January 1, 1993
Optimum method for growth hormone treatmentS L Smith, P C Hindmarsh, C G Brook
Clinical Endocrinology|April 10, 1999
The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumoursJ C Achermann, P C Hindmarsh, C G Brook
Pageof 20